Nls Pharmaceutics Ag Is A Swiss Biopharmaceutical Company Based In Zurichfocused On Developing Therapies For Rare And Complex Central Nervous Systemcnsdisordersfounded In 2015The Company Aims To Address Unmet Medical Needs In Neurologyparticularly In Sleep Disorders Like Narcolepsy And Idiopathic Hypersomniaas Well As Conditions Such As Adhd Nls Has A Robust Product Pipeline That Includes Quiliencea Phase 3 Treatment For Narcolepsy Related Excessive Daytime Sleepiness And Cataplexyand Nolazolan Adhd Therapy Partnered With Eurofarma For Distribution In Latin Americaother Candidates Target Long Covid Fatigue And Memory Impairmentthe Company Engages In Drug Discoveryclinical Developmentand Holds Multiple Patents For Its Neurological Treatmentsnls Collaborates With Institutions Like Stanford University And Has Strategic Partnerships With Pharmaceutical Companies To Enhance Its Research And Development Efforts
No conferences found for this company.
| Company Name | Nls 1 Pharma Inc |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
